Foreign drugmakers’ squeeze hits wholesalers

Multinational drug manufacturers, including Bayer Korea, are set to cut wholesalers’ profit margin to a 5-percent level from next year.

As a result, drug wholesalers will see their profits melt away, market officials claim.

They indicate that multinational firms’ margin cut plan is good for foreign chiefs whose achievements will be highly regarded by their headquarters and undoubtedly co...